Abstract
The search for a less aggressive and more biocompatible CPB circuit led to the development of miniaturised CPB, based on the idea of a closed oxygenator system which avoids contact of blood with air [1]. MECC integrates all the advances in CPB technology in one circuit specifically designed to minimise side effects from extracorporeal circulation. The essential components of a MECC circuit include (1) a blood pump, (2) a membrane oxygenator, (3) arterial and venous cannulae and (4) heparin-coated tubing to connect these devices. Blood–air interaction is avoided by eliminating the venous reservoir and cardiotomy suction. Thus, shed blood is completely separated from the systemic circulation [2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wiesenack C, Liebold A, Philipp A, Ritzka M, Koppenberg J, Birnbaum DE, Keyl C (2004) Four years’ experience with a miniaturized extracorporeal circulation system and its influence on clinical Âoutcome. Artif Organs 28:1082–1088
Mueller XM, Jegger D, Augstburger M, Horisberger J, Godar G, von Segesser LK (2002) A new concept of integrated cardiopulmonary bypass circuit. Eur J Cardiothorac Surg 21:840–846
Anastasiadis K, Chalvatzoulis O, Antonitsis P, Deliopoulos A, Argiriadou H, Karapanagiotidis G, Kambouroglou D, Papakonstantinou C (2011) Use of minimized extracorporeal circulation system in non-coronary and valve cardiac surgical procedures – a case series. Artif Organs 35:960–963
De Somer FM, Van Nooten G (2008) Blood pumps in cardiopulmonary bypass. In: Gravlee GP, Davis RF, Stamers AH, Ungerleider RM (eds) Cardiopulmonary bypass principles and practice, 3rd edn. Lippincott Wiliams & Wilkins, Philadelphia
Kolff J, McClurken JB, Alpern JB (1990) Beware centrifugal pumps: not a one-way street, but a dangerous siphon! Ann Thorac Surg 50:512
Kolff J, Ankney RN, Wurzel D, Devineni R (1996) Centrifugal pump failures. J Extra Corpor Technol 28:118–122
Pacheco DA, Ingram JM, Pacheco S (1992) A comparison of three centrifugal pumps’ ability to expel micro-air under conditions of cavitation or bolus air injection. Proc Am Acad Cardiovasc Perfusion 13:73–77
Zhang J, Gellman B, Koert A, Dasse KA, Gilbert RJ, Griffith BP, Wu ZJ (2006) Computational and experimental evaluation of the fluid dynamics and hemocompatibility of the CentriMag blood pump. Artif Organs 30:168–177
Takiura K, Masuzawa T, Endo S, Wakisaka Y, Tatsumi E, Taenaka Y, Takano H, Yamane T, Nishida M, Asztalos B, Konishi Y, Miyazoe Y, Ito K (1998) Development of design methods of a centrifugal pump with in vitro tests, flow visualization and computational fluid dynamics: results in hemolysis tests. Artif Organs 22:393–398
Tanaka M, Kawahito K, Adachi H, Isawa H, Ino T (2001) Platelet damage caused by the centrifugal pump: laser-light scattering analysis of aggregation patterns. Artif Organs 25:719–723
Nishinaka T, Nishida H, Endo M, Miyagishima M, Ohtsuka G, Koyanagi H (1996) Less blood damage in the impeller centrifugal pump: a comparative study with the roller pump in open heart surgery. Artif Organs 20:707–710
Morgan IS, Codispoti M, Sanger K, Mankad PS (1998) Superiority of centrifugal pump over roller pump in paediatric cardiac surgery: prospective randomised trial. Eur J Cardiothorac Surg 13:526–532
Ashraf SS, Tian Y, Cowan D, Shaikh R, Parsloe M, Martin P, Watterson KG (1997) Proinflammatory cytokine release during pediatric cardiopulmonary bypass: influence of centrifugal and roller pumps. J Cardiothorac Vasc Anesth 11:718–722
Baufreton C, Intrator L, Jansen PG, te Velthuis H, Le Besnerais P, Vonk A, Farcet JP, Wildevuur CR, Loisance DY (1999) Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. Ann Thorac Surg 67:972–977
Göbel C, Arvand A, Rau G, Reul H, Meyns B, Flameng W, Eilers R, Marseille O (2002) A new rotary blood pump for versatile extracorporeal circulation: the DeltaStream. Perfusion 17:373–382
Agati S, Mignosa C, Ciccarello C, Dario S, Undar A (2005) Pulsatile ECMO in neonates and infants: first European clinical experience with a new device. ASAIO J 51:508–512
Haneya A, Philipp A, Diez C, Ried M, Puehler T, Camboni D, Zausig Y, Lehle K, Schmid C (2009) Comparison of two different minimized extracorporeal circulation systems: hematological effects after coronary surgery. ASAIO J 55:592–597
Stammers AH, Trowbridge CC (2008) Principles of oxygenator function: gas exchange, heat transfer, and operation. In: Gravlee GP, Davis RF, Stamers AH, Ungerleider RM (eds) Cardiopulmonary bypass principles and practice, 3rd edn. Lippincott Wiliams & Wilkins, Philadelphia
Dutton RC, Edmunds LH Jr (1974) Formation of platelet aggregate emboli in a prototype hollow-fiber membrane oxygenator. J Biomed Mater Res 8:163
Chilton V, Klein A (2009) Equipment and monitoring. In: Ghosh S, Falter F, Cook DJ (eds) Cardiopulmonary bypass. Cambridge University Press, Cambridge
Panday GF, Fischer S, Bauer A, Metz D, Schubel J, El Shouki N, Eberle T, Hausmann H (2009) Minimal extracorporeal circulation and off-pump compared to conventional cardiopulmonary bypass in coronary surgery. Interact Cardiovasc Thorac Surg 9:832–836
Fromes Y, Gaillard D, Ponzio O, Chauffert M, Gerhardt MF, Deleuze P, Bical OM (2002) Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 22:527–533
Remadi JP, Rakotoarivello Z, Marticho P, Trojette F, Benamar A, Poulain H, Tribouilloy C (2004) Aortic valve replacement with the minimal extracorporeal circulation (Jostra MECC System) versus standard cardiopulmonary bypass: a randomized prospective trial. J Thorac Cardiovasc Surg 128:436–441
Gott VL, Whiffen JD, Datton RC (1963) Heparin surface bonding on colloidal graphite surface. Science 142:1297–1298
Levy M, Hartman AR (1996) Heparin-coated bypass circuits in cardiopulmonary bypass: improved biocompatibility or not. Int J Cardiol 53(Suppl):S81–S87
Wendel HP, Ziemer G (1999) Coating techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 16:342–350
Fujita M, Ishihara M, Ono K, Hattori H, Kurita A, Shimizu M, Mitsumaru A, Segawa D, Hinokiyama K, Kusama Y, Kikuchi M, Maehara T (2002) Adsorption of inflammatory cytokines using a heparin-coated extracorporeal circuit. Artif Organs 26:1020–1025
Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, Kuppe H (2002) Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management. Anesthesiology 97:837–841
Hsu LC (2001) Heparin-coated cardiopulmonary bypass circuits: current status. Perfusion 16:417–428
Videm V, Svennevig JL, Fosse E, Semb G, Osterud A, Mollnes TE (1992) Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 103:806–813
Gu YJ, van Oeveren W, Akkerman C, Boonstra PW, Huyzen RJ, Wildevuur CR (1993) Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55:917–922
Fosse E, Moen O, Johnson E, Semb G, Brockmeier V, Mollnes TE, Fagerhol MK, Venge P (1994) Reduced complement and granulocyte activation with heparin coated cardiopulmonary bypass. Ann Thorac Surg 58:472–477
Lundbland R, Moen O, Fosse E (1997) Endothelin-1 and neutrophil activation during heparin-coated Âcardiopulmonary bypass. Ann Thorac Surg 63:1361–1367
Muehrcke DD, McCarthy PM, Kottke-Marchant K, Harasaki H, Pierre-Yared J, Borsh JA, Ogella DA, Cosgrove DM (1996) Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial. J Thorac Cardiovasc Surg 112:472–483
Te Velthuis H, Jansen PGM, Hack CE, Eijsman L, Wildevuur CRH (1996) Specific complement inhibition with heparin-coated extracorporeal circuits. Ann Thorac Surg 61:1153–1157
Bouma M, Maessen J, Weerwind P, Dentener M, Fransen E, de Jong D, Buurman W (1997) Release of lipopolysaccharide toxicity-modulating proteins in patients undergoing cardiopulmonary bypass using noncoated and heparin-coated circuits. A clinical pilot study. Chest 111:577–583
Moen O, Hogasen K, Fosse E, Dregelid E, Brockmeier V, Venge P, Harboe M, Mollnes TE (1997) Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 63:105–111
Johnell M, Elgue G, Larsson R, Larsson A, Thelin S, Siegbahn A (2002) Coagulation, fibrinolysis and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface. J Thorac Cardiovasc Surg 124:321–332
Spiess B, Vocelka C, Cochran R, Soltow L, Chandler WL (1998) Heparin coated bypass circuits (Carmeda) suppress the release of tissue plasminogen activator during normothermic coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 12:299–304
Laffey JG, Boylan JF, Cheng DC (2002) The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 97:215–252
Von Segesser LK, Weiss BM, Pasic M, Garcia E, Turina MI (1994) Risk and benefit of low systemic heparinization during open heart operations. Ann Thorac Surg 58:391–398
Aldea GS, Doursounian BA, O’ Gara P, Treanor P, Shapira OM, Lazar HL, Shemin RJ (1996) Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study. Ann Thorac Surg 62:410–418
Ovrum E, Holen E, Tangen G, Brosstad F, Abdelnoor M, Ringdal MA, Oystese R, Istad R (1995) Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects. Ann Thorac Surg 60:365–371
Ranucci M, Mazzucco A, Pessotto R, Grillone G, Casati V, Porreca L, Maugeri R, Meli M, Magagna P, Cirri S, Giomarelli P, Lorusso R, de Jong A (1999) Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial. Ann Thorac Surg 67:994–1000
Heyer EJ, Lee KS, Manspeizer HE, Mongero L, Spanier TB, Caliste X, Esrig B, Smith C (2002) Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction. J Cardiothorac Vasc Anesth 16:37–42
Ovrum E, Tangen G, Tollofsrud S, Skeie B, Ringdal MA, Istad R, Oystese R (2011) Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 141:1145–1149
Wildevuur CR, Jansen PG, Bezemer PD, Kuik DJ, Eijsman L, Bruins P, De Jong AP, Van Hardevelt FW, Biervliet JD, Hasenkam JM, Kure HH, Knudsen L, Bellaiche L, Ahlburg P, Loisance DY, Baufreton C, Le Besnerais P, Bajan G, Matta A, Van Dyck M, Renotte MT, Ponlot-Lois A, Baele P, McGovern EA, Ahlvin E et al (1997) Clinical evaluation of Duraflo II heparin treated extracorporeal circulation circuits (2nd version). The European Working Group on heparin coated extracorporeal circulation circuits. Eur J Cardiothorac Surg 114:616–623
Suhara H, Sawa Y, Nishimura M, Oshiyama H, Yokoyama K, Saito N, Matsuda H (2001) Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model. Ann Thorac Surg 71:1603–1608
Ueyama K, Nishimura K, Nishina T, Nakamura T, Ikeda T, Komeda M (2004) PMEA coating of pump circuit and oxygenator may attenuate the early systemic inflammatory response in cardiopulmonary bypass surgery. ASAIO J 50:369–372
Tanaka M, Motomura T, Kawada M, Anzai T, Kasori Y, Shiroya T, Shimura K, Onishi M, Mochizuki A (2000) Blood compatible aspects of poly(2-methoxyethylacrylate) (PMEA)-relationship between protein adsorption and platelet adhesion on PMEA surface. Biomaterials 21:1471–1481
Skrabal CA, Khosravi A, Westphal B, Steinhoff G, Liebold A (2006) Effects of poly-2-methoxyethylacrylate (PMEA)-coating on CPB circuits. Scand Cardiovasc J 40:224–229
De Somer F, Francois K, van Oeveren W, Poelaert J, De Wolf D, Ebels T, Van Nooten G (2000) Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg 18:602–606
Ranucci M, Pazzaglia A, Isgro G, Cazzaniga A, Ditta A, Boncilli A, Cotza M, Carboni G, Brozzi S, Bonifazi C (2002) Closed, phosphorylcholine-coated circuit and reduction of systemic heparinization for cardiopulmonary bypass: the intraoperative ECMO concept. Int J Artif Organs 25:875–881
Ranucci M, Isgrò G, Soro G, Canziani A, Menicanti L, Frigiola A (2004) Reduced systemic heparin dose with phosphorylcholine coated closed circuit in coronary operations. Int J Artif Organs 27:311–319
Palatianos GM, Foroulis CN, Vassili MI, Astras G, Triantafillou K, Papadakis E, Lidoriki AA, Iliopoulou E, Melissari EN (2003) A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit. Ann Thorac Surg 761:129–135
Ranucci M, Balduini A, Ditta A, Boncilli A, Brozzi S (2009) A systematic review of biocompatible cardiopulmonary bypass circuits and clinical outcome. Ann Thorac Surg 87:1311–1319
Huybregts RM, Veerman DP, Vonk AB, Nesselaar AF, Paulus RC, Thone-Passchier DH, Smith AL, de Vroege R (2006) First clinical experience with the air purge control and electrical remote-controlled tubing clamp in mini bypass. Artif Organs 30:721–724
Mitsumaru A, Yozu R, Matayoshi T, Morita M, Shin H, Tsutsumi K, Iino Y, Kawada S (2001) Efficiency of an air filter at the drainage site in a closed circuit with a centrifugal blood pump: an in vitro study. ASAIO J 47:692–695
Morita M, Yozu R, Matayoshi T, Mitsumaru A, Shin H, Kawada S (2000) Closed circuit cardiopulmonary bypass with centrifugal pump for open-heart surgery: new trial for air removal. Artif Organs 24:442–445
Willcox TW, Mitchell SJ, Gorman DF (1999) Venous air in the bypass circuit: a source of arterial line emboli exacerbated by vacuum assisted drainage. Ann Thorac Surg 68:1285–1289
Nollert G, Schwabenland I, Maktav D, Kur F, Christ F, Fraunberger P, Reichart B, Vicol C (2005) Miniaturized cardiopulmonary bypass in coronary artery bypass surgery: marginal impact on inflammation and coagulation but loss of safety margins. Ann Thorac Surg 80:2326–2332
Roosenhoff TP, Stehouwer MC, De Vroege R, Butter RP, Van Boven WJ, Bruins P (2010) Air removal efficiency of a venous bubble trap in a minimal extracorporeal circuit during coronary artery bypass grafting. Artif Organs 34:1092–1098
Gerriets T, Schwarz N, Sammer G, Baehr J, Stolz E, Kaps M, Kloevekorn WP, Bachmann G, Schönburg M (2010) Protecting the brain from gaseous and solid micro-emboli during coronary artery bypass grafting: a randomized controlled trial. Eur Heart J 31:360–368
Immer FF, Pirovino C, Gygax E, Englberger L, Tevaearai H, Carrel TP (2005) Minimal versus conventional cardiopulmonary bypass: assessment of intraoperative myocardial damage in coronary bypass surgery. Eur J Cardiothorac Surg 28:701–704
Takai H, Eishi K, Yamachika S, Hazama S, Ariyoshi T, Nishi K (2005) Demonstration and operative influence of low prime volume closed pump. Asian Cardiovasc Thorac Ann 13:65–69
Shiiya N, Matsuzaki K, Kunihara T, Yasuda K (2005) Use of a soft reservoir bag in a fully heparin-coated closed-loop cardiopulmonary bypass system for distal aortic perfusion during aortic surgery. J Artif Organs 8:85–90
Ranucci M, Pavesi M, Mazza E, Bertucci C, Frigiola A, Menicanti L, Ditta A, Boncilli A, Conti D (1994) Risk factors for renal dysfunction after coronary surgery: the role of cardiopulmonary bypass technique. Perfusion 9:319–326
Ranucci M, Romitti F, Isgrò G, Cotza M, Brozzi S, Boncilli A, Ditta A (2005) Oxygen delivery during cardiopulmonary bypass and acute renal failure following coronary operations. Ann Thorac Surg 80:2213–2220
Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A (2003) Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg 125:1438–1450
Brown Mahoney C, Donnelly JE (2000) Impact of closed versus open venous reservoirs on patient outcome in isolated coronary bypass surgery. Perfusion 15:467–472
Eisses MJ, Seidel K, Aldea GS, Chandler WL (2004) Reducing hemostatic activation during cardiopulmonary bypass: a combined approach. Anesth Analg 98:1208–1216
von Segesser LK, Tozzi P, Mallbiabrrena I, Jegger D, Horisberger J, Corno A (2003) Miniaturization in cardiopulmonary bypass. Perfusion 18:219–224
Ranucci M, Castelvecchio S (2009) Management of mini-cardiopulmonary bypass devices: is it worth the energy? Curr Opin Anaesthesiol 22:78–83
Rahe-Meyer N, Solomon C, Tokuno ML, Winterhalter M, Shrestha M, Hahn A, Tanaka K (2010) Comparative assessment of coagulation changes induced by two different types of heart-lung machine. Artif Organs 34:3–12
Ovrum E, Brosstad F, Am Holen E, Tangen G, Abdelnor M (1995) Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass. Circulation 92:2579–2584
Benedetto U, Luciani R, Goracci M, Capuano F, Refice S, Angeloni E, Roscitano A, Sinatra R (2009) Miniaturized cardiopulmonary bypass and acute kidney injury in coronary artery bypass graft surgery. Ann Thorac Surg 88:529–535
Agati S, Ciccarello G, Trimarchi ES, Grasso D, Trimarchi G, Di Stefano S, Carmelo M (2007) Extracorporeal circulation, optimized: a pilot study. Artif Organs 31:377–383
Ti LK, Goh LB, Wong PS, Patsy Ong P, Goh SG, Lee CN (2008) Comparison of mini-cardiopulmonary bypass system with air-purge device to conventional bypass system. Ann Thorac Surg 85:994–1001
Kutschka I, Skorpil J, El Essawi A, Hajek T, Harringer W (2009) Beneficial effects of modern perfusion concepts in aortic valve and aortic root surgery. Perfusion 24:37–44
Yamut T (2002) FDA 51O(k) Premarket notification. Cardiovention CORx System K012325 http://www.accessdata.fda.gov/cdrh_docs/pdf/k012325.pdf
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Anastasiadis, K., Antonitsis, P., Argiriadou, H. (2013). MECC Equipment. In: Principles of Miniaturized ExtraCorporeal Circulation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-32756-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-32756-8_3
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-32755-1
Online ISBN: 978-3-642-32756-8
eBook Packages: MedicineMedicine (R0)